🇺🇸 FDA
Pipeline program

botulinum toxin type A

191622-090

Phase 2 mab completed

Quick answer

botulinum toxin type A for Cervical Dystonia is a Phase 2 program (mab) at Allergan Pharmaceuticals International Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Allergan Pharmaceuticals International Limited
Indication
Cervical Dystonia
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials